Four Reasons Behind BofA's Bullish Restorbio Initiation By: Benzinga via Benzinga February 20, 2018 at 16:26 PM EST Clinical-stage biopharma resTORbio, Inc. (NASDAQ: TORC) went publicJan. 26, offering 5.67 million shares at $15 ... Read More >> Related Stocks: Restorbio Inc